Skip to content
10-K

Annual Report

BIOSCIENCE NEUTRACEUTICALS, INC.

0001640334-18-000706

← back to feed
Filed
Apr 12, 2018 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2017 · Apr 10, 2018 9.7M sh
Gross Profit FY 2017 · Dec 31, 2017 $1.85K
Revenue FY 2017 · Dec 31, 2017 $7.76K
Operating Cash Flow FY 2017 · Dec 31, 2016 −$6K
Current Liabilities FY 2017 · Dec 31, 2016 $17.37K
Total Liabilities FY 2017 · Dec 31, 2016 $17.37K
Sga Expense restated FY 2017 · Dec 31, 2016 $3.68K
Net Income FY 2017 · Dec 31, 2016 −$14.06K
Operating Income FY 2017 · Dec 31, 2016 −$10.76K
Cash And Equivalents FY 2017 · Dec 31, 2015 $1.67K
Stockholders Equity FY 2017 · Dec 31, 2015 −$3.31K